WeVote
Log In

Bill

Bill

A 4944

Requires DOH to evaluate hospital compliance with federal hospital price transparency requirements.

2026-2027 Regular Session

The bill requires the New Jersey Department of Health to evaluate and report on hospitals’ compliance with federal price transparency rules.

Introduced, Referred to Assembly Health Infrastructure Committee
0
WeVote Research Nonpartisan
Bill Summary · A 4944

Summary of New Jersey Assembly Bill A-4944 (Session 222)

Title

Requires Department of Health (DOH) to evaluate hospital compliance with federal hospital price transparency requirements.

Main purpose and intent

  • To ensure New Jersey hospitals are meeting federal price transparency rules by requiring a state-level evaluation of compliance.
  • Aims to protect consumers by verifying hospitals publish accessible and accurate price information as mandated by federal law.

Key provisions and changes

  • New requirement for DOH evaluation: The bill mandates the New Jersey Department of Health to assess and report on hospitals’ compliance with federal hospital price transparency requirements.
  • Scope of evaluation:
    • Likely focuses on whether hospitals publish and maintain clear, machine-readable pricing data for standard services and procedures, as required by federal rules (e.g., 45 CFR 180.230 and related guidance, though the bill text would specify exact federal references).
    • May include verification of posted data in plain language summaries and/or downloadable datasets, including shoppable prices and standard charge information where applicable.
    • Could involve checking timeliness, accuracy, and accessibility (e.g., availability on hospital websites, searchable formats, and compliance with formatting standards).
  • Reporting requirements: The DOH would be required to produce a report detailing findings, deficiencies, and recommended corrective actions or timelines for noncompliant hospitals.
  • Potential follow-up actions: The bill may authorize the DOH to provide guidance, impose corrective measures, or coordinate with federal regulators if noncompliance is identified, though specific enforcement mechanisms would be defined in the bill text.

Who would be affected

  • Hospitals and health systems in New Jersey: Hospitals subject to federal price transparency rules would be the primary focus of the DOH evaluation.
  • DOH and state agencies: Responsible for conducting the evaluation, compiling data, and issuing the required report.
  • NJ consumers and payors: Improved transparency and accountability could lead to easier access to pricing information for patients, employers, and insurers.

Procedural and timeline aspects

  • Action by the DOH: Initiates an evaluation of hospital price transparency compliance.
  • Reporting timeline: The bill would specify deadlines for the DOH to complete the evaluation and submit a report to the Legislature (e.g., within a defined fiscal year or number of months after enactment). The exact deadline would be specified in the bill text.
  • Next steps: Depending on the report findings, the Legislature could consider additional oversight measures, regulatory actions, or policy adjustments.

Potential impact and considerations

  • By formalizing an evaluation process, the bill aims to improve adherence to federal price transparency standards, which can enhance price visibility for patients and third-party payors.
  • The effectiveness depends on the DOH’s authority to enforce recommendations and the specificity of the evaluation criteria outlined in the bill.
  • The bill aligns with ongoing national efforts to increase hospital price transparency and consumer access to pricing information.

If you’d like, I can tailor this summary to include direct quotations or specific sections from the bill text, or add a comparison with the federal price transparency requirements as they relate to New Jersey.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.